CAM
INSM icon

ClariVest Asset Management’s Insmed INSM Stock Holding History

ClariVest Asset Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$738K Hold
11,015
– – 0.08% 310
2024
Q2 		$738K Buy
+11,015
New +$427K 0.08% 310

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClariVest Asset Management's INSM Position: Q3 2024 in Review

ClariVest Asset Management held its Insmed (INSM) position steady in Q3 2024 at 11,015 shares worth $738K. The position accounts for 0.08% of the portfolio, ranked #310.

ClariVest Asset Management first reported a position in INSM in Q2 2024 and has held it in 2 quarters since. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • ClariVest Asset Management held 11,015 shares of Insmed worth $738K as of Q3 2024.
  • ClariVest Asset Management left its Insmed share count unchanged in Q3 2024.
  • Insmed made up 0.08% of ClariVest Asset Management's portfolio in Q3 2024, its #310 holding.
  • ClariVest Asset Management first reported a position in Insmed in Q2 2024 and has held it in 2 quarters since.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.